Kanya Rajangam

Insider Reports History

Entity
Individual
Location
C/O Senti Biosciences, Inc., 2 Corporate Drive, First Floor, South San Francisco, CA
Signature
/s/ Venkat Ramanan, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Kanya Rajangam:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Nkarta, Inc. Chief Medical Officer Common Stock 12.8K $112K $8.74 Jan 14, 2022 Direct
Senti Biosciences, Inc. Chief Medical & Devt. Officer Stock Option (Right to Buy) 152K Feb 1, 2024 Direct
Senti Biosciences, Inc. Chief Medical & Devt. Officer Common Stock 101K Feb 1, 2024 Direct
Nkarta, Inc. Chief Medical Officer Stock Option (right to buy) 76.8K Jan 14, 2022 Direct
Turnstone Biologics Corp. Director Stock Option (Right to Buy) 12.8K Jun 3, 2024 Direct

Insider Reports Filed by Kanya Rajangam

Symbol Company Period Transactions Value $ Form Type Date Filed Role
TSBX Turnstone Biologics Corp. Jun 3, 2024 1 $0 4 Jul 2, 2024 Director
SNTI Senti Biosciences, Inc. Feb 1, 2024 2 $0 4 Feb 2, 2024 Chief Medical & Devt. Officer
TSBX Turnstone Biologics Corp. Oct 16, 2023 1 $0 4 Oct 17, 2023 Director
TSBX Turnstone Biologics Corp. Jul 20, 2023 0 $0 3 Jul 20, 2023 Director
SNTI Senti Biosciences, Inc. Feb 1, 2023 1 $0 4 Feb 2, 2023 Chief Medical & Devt. Officer
SNTI Senti Biosciences, Inc. Jul 18, 2022 1 $0 4 Jul 20, 2022 Chief Medical & Devt. Officer
SNTI Senti Biosciences, Inc. Jul 5, 2022 0 $0 3 Jul 15, 2022 Chief Medical & Devt. Officer
NKTX Nkarta, Inc. Jan 14, 2022 2 $0 4 Jan 19, 2022 Chief Medical Officer
NKTX Nkarta, Inc. Aug 5, 2021 3 -$369K 4 Aug 9, 2021 Chief Medical Officer